Testing for Human Immunodeficiency Virus Among Cancer Survivors Under Age 65 in the United States

INTRODUCTION: Knowing the human immunodeficiency virus (HIV) serostatus of patients at the time of cancer diagnosis or cancer recurrence is prerequisite to coordinating HIV and cancer treatments and improving treatment outcomes. However, there are no published data about HIV testing among cancer sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun, Thompson, Trevor D., Tai, Eric, Zhao, Guixiang, Oster, Alexandra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232332/
https://www.ncbi.nlm.nih.gov/pubmed/25393748
http://dx.doi.org/10.5888/pcd11.140274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232332/
https://www.ncbi.nlm.nih.gov/pubmed/25393748
http://dx.doi.org/10.5888/pcd11.140274

Ejemplares similares